VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
WHGAX
Price
$21.94
Change
+$0.06 (+0.27%)
Updated
Jul 31 closing price
Net Assets
874.81M
Interact to see
Advertisement

VSCIX vs WHGAX

VSCIX vs WHGAX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. WHGAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and WHGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. WHGAX (875M). VSCIX pays higher dividends than WHGAX: VSCIX (1.23) vs WHGAX (0.54). VSCIX was incepted earlier than WHGAX: VSCIX (29 years) vs WHGAX (7 years). WHGAX (1.18) is less costly to investors than VSCIX (0.03). WHGAX is a more actively managed with annual turnover of: 63.00 vs. VSCIX (17.00). WHGAX has a lower initial minimum investment than VSCIX: WHGAX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. WHGAX (9.26). VSCIX return over 5 years is better than : 35.13 vs. WHGAX (9.39).
VSCIXWHGAXVSCIX / WHGAX
Total Expense Ratio0.031.043%
Annual Report Gross Expense Ratio0.031.183%
Fund Existence29 years7 years-
Gain YTD14.59115.23196%
Front LoadN/A4%-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets189B875M21,600%
Annual Yield % from dividends1.230.54226%
Returns for 1 year22.589.26244%
Returns for 3 years43.4411.87366%
Returns for 5 years35.139.39374%
Returns for 10 years156.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C